Resilience Investment Holdings Ltd Commences the Voluntary Recommended Public Cash Tender Offer for all Shares and Equity Securities in Tecnotree

A consortium led by Helios, with Fitzroy Investments and Tecnotree CEO Padma Ravichander, through Offeror Resilience Investment Holdings Ltd has launched a recommended cash tender offer for Tecnotree at EUR 5.70 per share (based on 17,016,693 outstanding shares), EUR 145,823.10 per CCD (231 CCDs), EUR 100 per 100,000 warrants (23,100,000 warrants) and EUR 0.01 per 20 options (18,153,850 options); the offer period runs from Feb 5 to Mar 25, 2026 and completion is expected in Q2 2026. The Tecnotree board unanimously recommends the offer, major shareholders (including Ravichander and Fitzroy) have irrevocably committed substantial conversions and contributions of shares, warrants and options, and the offer is conditional on regulatory approvals and the Offeror acquiring 90% of diluted shares and voting rights.

Analysis

Market structure: The consortium (Helios + Fitzroy + CEO Ravichander) has locked in ~63% of existing shares post‑conversion (≈10.7m of 17.0m), leaving a ~27–30% free float that the Offeror must capture to hit the 90% diluted control condition. If the market price trades materially below the €5.70 offer price, expect concentrated buy orders from the Offeror and advisors driving intraday/short‑term upside and reduced float; failure to reach 90% will create binary downside risk (20–50% hole). Liquidity flows will be concentrated on Nasdaq Helsinki small‑cap trading windows (Feb 5–Mar 25) and could temporarily tighten bid/ask spreads.

Risk assessment: Key tail risks are (1) failure to obtain 90% on a diluted basis by final result (offer lapses), (2) regulatory or antitrust objections in jurisdictions of Tecnotree customers, and (3) a competing bid that pushes price above €5.70. Time horizons: immediate (days) — buy interest and volatility spike; short (weeks) — acceptance notifications (prelim result ~first banking day after Mar 25) will reprice; long (quarters) — delisting/privatization or integration by Helios. Hidden dependency: CCD/Warrant conversion mechanics materially change denominator; any new issuance/dividend before close will trigger euro‑for‑euro downward adjustment of offer price.

Trade implications: Pure arbitrage — buy Tecnotree shares only when market ≤€5.30 (implied ≥7.5% upside to €5.70) size 1–3% NAV and hedge with 1–2 month puts (strike €5.00) to cap downside to ~10–15%. If stock rallies to ≥€5.60 with improving acceptances, sell into strength (target exit ≥€5.65). If stock >€5.80 pre‑expiry, establish a small short (stop €6.00) anticipating failed offer or competing bidder unwind. Cross‑asset: minimal FX/commodity impact; fixed income holders of corporate debt see minor credit relief on conversion but monitor any cash funded purchases by Offeror for liquidity drain.

Contrarian angles: Consensus treats €5.70 as near‑certain floor; that's mistaken unless the Offeror clears 90% diluted. The market may underprice failure risk — buy only at ≥10% discount to €5.70 unless you can tender. Historical parallels: small‑cap European takeovers often fail the supermajority test and drop 25–40% when they lapse. Unintended consequence: aggressive open‑market accumulation by consortium could trigger competing bids or regulatory scrutiny, which would widen spreads and create both liquidity and timing risks.

Key Decisions for Investors

• Establish a 1–3% NAV long position in Tecnotree (buy shares) only if market price ≤ €5.30 before Mar 25, 2026; simultaneously purchase 1–2 month €5.00 puts (or nearest liquid protection) to limit downside to ~10–15%; plan to tender into the offer if you hold through expiration.
• If Tecnotree trades ≥ €5.60 with public indications that acceptances exceed ~75% (prelim release), trim/exit long position and realize gains at ≥ €5.65; redeploy capital elsewhere.
• Do not chase above €5.70; consider initiating a small (0.5–1% NAV) short if price > €5.80 before the offer close with a strict stop at €6.00 — reward is limited if offer lapses or competing bidder withdraws.
• Monitor three binary catalysts and act within 24–72 hours of each: (A) preliminary result (first banking day after Mar 25) — acceptance %; (B) final result (third banking day after expiry) — completion yes/no; (C) any regulatory approval delays. Reduce position by 50% if acceptance <70% or increase to full 3% NAV if acceptance >85%.